Table 3 Effect of tranexamic acid (TXA) on death or hysterectomy by subgroups
Subgroup | TXA | Placebo | Risk ratio (99 % CI) | ||
|---|---|---|---|---|---|
Death or hysterectomy | Received TXA | Death or hysterectomy | Received Placebo | ||
Time between delivery and randomisation: | |||||
≤ 1 h | NN (X %) | N NNN | NN (X %) | N NNN | X.XX (X.XX–X.XX) |
1–3 h | NN (X %) | N NNN | NN (X %) | N NNN | X.XX (X.XX–X.XX) |
> 3 h | NN (X %) | N NNN | NN (X %) | N NNN | X.XX (X.XX–X.XX) |
(p = 0.XXX)* | |||||
Type of delivery: | |||||
Vaginal | NN (X %) | N NNN | NN (X %) | N NNN | X.XX (X.XX–X.XX) |
Caesarean section | NN (X %) | N NNN | NN (X %) | N NNN | X.XX (X.XX–X.XX) |
(p = 0.XXX) | |||||
Primary cause of haemorrhage: | |||||
Uterine atony | NN (X %) | N NNN | NN (X %) | N NNN | X.XX (X.XX–X.XX) |
Other/unknown | NN (X %) | N NNN | NN (X %) | N NNN | X.XX (X.XX–X.XX) |
(p = 0.XXX) | |||||